文献速递腹部介入MR

基于多参数钆塞酸二钠增强MRI特征的热消融与手术切除治疗肝细胞癌疗效比较:一项回顾性队列研究

Efficacy of Thermal Ablation vs. Surgical Resection for Hepatocellular Carcinoma Based on Multiparametric EOB-MRI Features: A Retrospective Cohort Study.
PubMed 文献 · Acad Radiol · 2026-03-09

该回顾性队列研究基于多参数钆塞酸二钠增强MRI特征,比较热消融与手术切除治疗早期肝细胞癌的疗效。倾向性评分匹配后每组50例,两组总生存期(log-rank p=0.822)和无病生存期(log-rank p=0.268)均无显著差异;消融组中甲胎蛋白升高是影响无病生存期的独立危险因素(HR=1.88,95%CI 1.04-3.39,p=0.037)。

要点

  • 倾向性评分匹配后热消融与手术切除治疗早期肝细胞癌的总生存期和无病生存期均无显著差异。
  • 消融组中甲胎蛋白升高是无病生存期的独立危险因素(HR=1.88,95%CI 1.04-3.39,p=0.037)。
  • 按肿瘤位置、大小及白蛋白-胆红素分级分层后,两组生存结局仍无统计学显著差异(均p>0.05)。

核心结论

  • 本研究表明,热消融与手术切除治疗早期肝细胞癌的疗效相似,患者生存结局相当。

研究设计与样本

  • 回顾性队列研究,纳入2016年1月至2021年8月在本院接受热消融或手术切除的早期肝细胞癌患者,初始热消融组92例、手术切除组181例,经1:1最近邻倾向性评分匹配平衡19项预设协变量后每组50例;采用标准化影像协议和盲法共识阅片,以Kaplan-Meier曲线和Cox比例风险回归分析生存结局。

诊断标准与关键数值

  • 匹配后热消融组与手术切除组总生存期比较log-rank p=0.822,无显著差异。
  • 匹配后热消融组与手术切除组无病生存期比较log-rank p=0.268,无显著差异。
  • 匹配后按肿瘤位置、大小及白蛋白-胆红素分级分层的亚组分析中,总生存期和无病生存期均无统计学显著差异(均p>0.05)。
  • 消融组Cox分析显示甲胎蛋白升高影响无病生存期的风险比HR=1.88(95%CI 1.04-3.39,p=0.037)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This retrospective study compared thermal ablation (TA) and surgical resection (SR) in treating hepatocellular carcinoma (HCC) based on multiparametric gadoxetic acid-enhanced MRI features, with an emphasis on the impact of tumor location, size, and liver function reserve.

MATERIALS AND METHODS: Patients with early-stage HCC treated with either TA or SR at our hospital from January 2016 to August 2021 were included. Propensity score matching (PSM) with a 1:1 nearest-neighbor algorithm was employed to balance nineteen predefined covariates across treatment groups. Standardized imaging protocols and blinded consensus review were implemented. Survival outcomes, including overall survival (OS) and disease-free survival (DFS), were analyzed using Kaplan-Meier curves and Cox proportional hazards regression. Subgroup analyses stratified by tumor topography, size, and albumin-bilirubin grade were performed.

RESULTS: Initially, 92 patients in the TA group and 181 patients in the SR group were included. After PSM, a balanced cohort of 50 patients in each group was achieved. No significant differences in OS (log-rank p = 0.822) or DFS (log-rank p = 0.268) were found between the TA and SR groups. The subgroup analyses after matching demonstrated no statistically significant differences in OS or DFS across the stratified groups (all p > 0.05). Further Cox analysis revealed that elevated alpha-fetoprotein (hazard ratio = 1.88, 95% CI: 1.04-3.39, p = 0.037) was an independent risk factor affecting DFS in the ablation group.

CONCLUSION: This study indicates that TA and SR offer similar therapeutic outcomes in early-stage HCC, with comparable survival outcomes for patients.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Xing T, Jiang S, Zhang H, et al. Efficacy of Thermal Ablation vs. Surgical Resection for Hepatocellular Carcinoma Based on Multiparametric EOB-MRI Features: A Retrospective Cohort Study. Acad Radiol. 2026. PMID: 41807162. doi:10.1016/j.acra.2026.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。